Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves PF-708 for osteoporosis

Oct. 10, 2019

AgenTus Therapeutics develops T-cell receptor candidate targeting NY-ESO-1

Oct. 10, 2019

Affimed Therapeutics divulges EGFR- and CD16A-targeting proteins

Oct. 10, 2019

Evelo Biosciences presents new Tyzzerella nexilis bacterial compositions

Oct. 10, 2019

Beijing Tide Pharmaceutical synthesizes AGTR2 antagonists

Oct. 10, 2019

Roche divulges new MGL inhibitors

Oct. 10, 2019

Chinese investigators patent ROCK inhibitors

Oct. 10, 2019

RCC2 as a novel therapeutic target in glioblastoma

Oct. 10, 2019

Results from OS analysis of KATE2 study of atezolizumab plus T-DM1 in HER2+ advanced BC

Oct. 10, 2019

Improved gamma-gamma cross-linking could hep prevent thromboembolic diseases

Oct. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.